Erick Lucera Editas Medicine, Inc. (EDIT) insider trading activity

EDIT Quotes by TradingView

Erick Lucera is EVP, CHIEF FINANCIAL OFFICER of Editas Medicine, Inc.. Currently has a direct ownership of 116,829 shares of EDIT, which is worth approximately $419,416. The most recent transaction as insider was on May 20, 2024, when has been sold 22,337 shares (Common Stock) at a price of $5.61 per share, resulting in proceeds of $125,310. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 117K
0% 3M change
49.97% 12M change
Total Value Held $419,416

Erick Lucera Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 20 2024
SELL
Open market or private sale
$125,310 $5.61 p/Share
22,337 Reduced 16.05%
116,829 Common Stock
Mar 02 2024
BUY
Grant, award, or other acquisition
-
61,266 Added 30.57%
139,166 Common Stock
May 17 2023
BUY
Grant, award, or other acquisition
-
77,900 Added 50.0%
77,900 Common Stock

Also insider at

AVEO
AVEO PHARMACEUTICALS, INC. Healthcare
Chief Financial Officer
XAIR
Beyond Air, Inc. Healthcare
Director
SABS
SAB Biotherapeutics, Inc. Healthcare
BBLG
Bone Biologics Corp Healthcare
Director
EL

Erick Lucera

EVP, CHIEF FINANCIAL OFFICER
Boston, MA

Track Institutional and Insider Activities on EDIT

Follow Editas Medicine, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells EDIT shares.

Notify only if

Insider Trading

Get notified when an Editas Medicine, Inc. insider buys or sells EDIT shares.

Notify only if

News

Receive news related to Editas Medicine, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on EDIT